report
7.8 References

[1]                   R.A. Freitas, Nanomedicine: Nanotechnology, Biology, and Medicine 1 (2005) 2-9

[2]                   W.E. Bawarski, E. Chidlowsky, D.J. Bharali, S.A. Mousa, Nanomedicine: Emerging nanopharmaceuticals Volume 4, Issue 4, (2008) 273-282

[3]                   Interagency Working Group on Nanoscience, Engineering and Technology of the National Science and Technology Council´s Committee on Technology, "National Nanotechnology Initiative: Leading to the Next Industrial Revolution," Washington D.C., 2000

[4]                   National Science and Technology Council (NSTC) Committee on Technology and the Interagency Working Group on NanoScience, Engineering and Technology (IWGN), edited by R.W. Siegel, E. Hu, M.C. Roco, WTEC, Loyola College in Maryland, "Nanostructure Science and Technology ‑ A Worldwide Study," 2000

[5]                   with courtesy from Dr. Werner Grünwald, Bosch GmbH

[6]                   Nanomedicine: Nanotechnology for Health, European Strategic Research Agenda for Nanomedicine, November 2006; ftp://ftp.cordis.europa.eu/pub/nanotechnology/docs/nanomedicine_bat_en.pdf

[7]                   European Technology Platform on NanoMedicine Nanotechnology for Health: Vision Paper and Basis for a Strategic Research Agenda (SRA) for NanoMedicine, September 2005; ftp://ftp.cordis.europa.eu/pub/nanotechnology/docs/nanomedicine_visionpaper.pdf

[8]                   V. Wagner et al, The emerging nanomedicine landscape, Nature Biotechnology, Vol. 24(10), October 2006

[9]                   EPODOC database, 1993-2003, European Patent Office, Rijswijk, The Netherlands

[10]                 http://www.nsf.gov/statistics/seind08/c6/c6s7.htm

[11]                 S. Middleton, Barriers to Innovation in the Development of New Medicines in Europe and Possible Solutions to Address these Barriers, GlaxoSmithKline, September 2004.

[12]                 http://www.sas.com/success/elililly.html

[13]                 http://www.mindbranch.com/listing/product/R566-0115.html

[14]                 http://www.innovations-report.de/html/berichte/studien/bericht-37539.html

[15]                 http://www.prleap.com/pr/77509/

[16]                 http://www.aap.de/en/Produkte/Orthobiologie/Knochenersatz/Ostim/index_html

[17]                 http://www.aap.de/en/Produkte/Orthobiologie/Knochenersatz/PerOssal/index_html

[18]                 http://www.orthovita.com/vitoss/

[19]                 aap, MEBIO, Annual Report 2005

[20]                 http://www.swissinfo.org/eng/search/Result.html?siteSect=882&ty=st&sid=7576024

[21]                 http://www.aap.de/en/Unternehmen/Konzernstruktur/Osartis/index_html

[22]                 http://www.aap.de/en/Home/index_html

[23]                 http://www.dentsply.com/assets/investors/InvestorPresentationMay12008.pdf

[24]                 http://www.freedoniagroup.com/Dental-Products-And-Materials.html

[25]                 http://internationaltrade.suite101.com/article.cfm/top_global_dental_supplier

[26]                 http://www.dentsply.de/bausteine.net/file/showfile.aspx?downdaid=6913&sp=D&domid=1042        &fd=2

[27]                 UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT No. 03-4097, UNITED STATES OF AMERICA, Appellant v. DENTSPLY INTERNATIONAL, INC., APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE, (D.C. Civ. No. 99-00005), District Judge: Honorable Sue L. Robinson, Chief Judge, Argued September 21, 2004

[28]                 http://www.heraeus.com/HH%5Ceng%5Cholding_resources.nsf/$files/download_rating_moodys_2006.pdf/$file/rating_moodys_2006.pdf

[29]                 http://www.dentsply.com/assets/investors/280954A._LR.pdf

[30]                 http://www.dentsply.com/default.aspx?pageid=25

[31]                 http://www.prnewswire.co.uk/cgi/news/release?id=132642

[32]                 http://www.frost.com/prod/servlet/market-insight-top.pag?docid=110259949

[33]                 http://www.freedoniagroup.com/brochure/21xx/2137smwe.pdf

[34]                 The U.S market for medical imaging contrast media, report 260, Bio-Tech Systems, Inc., 2007

[35]                 http://www.reuters.com/article/pressRelease/idUS177311+30-Apr-2008+BW20080430

[36]                 http://www.mritutor.org/mritutor/contrast.htm

[37]                 http://nano.cancer.gov/news_center/nanotech_news_2005-10-03b.asp

[38]                 Frost & Sullivan's Analysis Of The European Contrast Media Market, Press Release, October 2002

[39]                 http://www.viva.vita.bayerhealthcare.com/index.php?id=386&tx_ttnews%5Btt_news%5 D=12480&cHash=c492fd0939

[40]                 http://www.reuters.com/article/pressRelease/idUS177311+30-Apr-2008+BW20080430

[41]                 http://www.freedoniagroup.com/brochure/21xx/2137smwe.pdf

[42]                 http://www.snl.com/Cache/1001145633.PDF?D=&O=PDF&IID=4166432&Y=&T=&FID=1001145633

[43]                 http://www.evaluatepharma.com/CoInfo/CoInfo-GUER.htm

[44]                 AMAG Pharmaceutical Inc., Annual Report 2006

[45]                 http://www.viva.vita.bayerhealthcare.com/fileadmin/user_upload/Koestlin_Marketed_Products.pdf